22 Nov

Appendix 3Y Change of Directors Interest Notice

Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity HEALIUS LIMITED ABN 24 064 530 516 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Jennifer Macdonald Date of last notice 02 September 2021 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. N/A Date of change 19 November 2021 No. of securities held prior to change 35,000 Class NED Share Rights Number acquired 12,048 Number disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation $60,000 cash equivalent using the volume weighted average price of Ordinary Shares over the five business days immediately following the Healius Limited Annual General Meeting on 21 October 2021, being $4.98. No. of securities held after change 12,048 NED Share Rights 35,000 Ordinary shares Jennifer Macdonald Jennifer Macdonald Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y Page 2 01/01/2011 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back Issue of Securities under the NED Share Plan. Part 2 – Change of director’s interests in contracts Not applicable Part 3 – + Closed period Were the interests in the securities or contracts detailed above traded during a + closed period where prior written clearance was required? N/A If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A Authorised by the Company Secretary. Charles Tilley Company Secretary Date: 22 November 2021
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Healius Limited (ASX:HLS) when you join Listcorp.